Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care - The triumph project

European Urology

Volumn 42, Issue 4, 2002, Pages 323-328

  Verhamme, K M C ^a,b   Dieleman, J P ^a,b   Bleumink, G S ^a,b   Van der Lei, J ^a,b   Sturkenboom, M C J M ^a,b  

^a Pharmaco Epidemiology Unit   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Benign prostatic hyperplasia; Electronic patient record; Incidence; IPCI; Lower urinary tract symptoms; Prevalence; Triumph

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; DATA BASE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PRIMARY HEALTH CARE; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY; AGING; BLADDER IRRITATION; MICTURITION; MORBIDITY; PRIORITY JOURNAL; SYMPTOM; URETHRA; URINARY TRACT DISEASE;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PRIMARY HEALTH CARE; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES;

EID: 0036793976     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00354-8     Document Type: Article

References (19)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132(3):474-9.
2. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993;150:351-8.
3. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hyperplasia in the community. Lancet 1991;338:469-71.
4. Chute CG, Panser L, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993;150:85-9.
5. Sagnier PP, Macfarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol 1994;151:1266-70.
6. Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez-Cruz JJ, del Rosal-Samaniego JM, Dodero-Garcia P, Rodriguez-Vallejo JM. Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older. J Urol 1998;159:878-82.
7. Bosch RJLH, Hop WCJ, Kirkels WJ, Schroder FH. Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community. Urology 1995;46(Suppl 3A):34-40.
8. Napalkov P. Maisonneuve P, Boyle P. Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia. Urology 1995;46(Suppl 3A):41-6.
9. Ozturk A, Serel TA, Kosar A, Kecelioglu M. Prevalence of benign hyperplasia of the prostate in Turkish men hospitalized in urology. Prog Urol 2000;10(4):568-70.
10. Sagnier PP, Girman CJ, Garraway M, Kumamoto Y, Lieber MM, Richard F, et al. International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 1996;29(1):15-20.
11. Clifford M, Logie J, Farmer RDT. How do symptoms indicative of BPH progress in real life practice? The UK experience. Eur Urol 2000;38(Suppl 1):48-53.
12. Klomp MLF, Germaca AJ, De Jonge-Wubben JGM, Mulders AHPW, Romeijnders ACM, Rosmalen CFH, et al. NHG standards, M42: micturition difficulties in elderly men. Huisarts en Wetenschap 1997;40(3):114-24.
13. Chapple RC. Lower urinary tract symptoms suggestive of BPH-TRIUMPH: design and implementation. Eur Urol 2001;39(Suppl 3):31-6.
14. Schrijvers AJP. Health and Health Care in The Netherlands. A critical self-assessment of Dutch experts in medical and health sciences. Utrecht: De Tijdstroom; 1997.
15. van der Lei J, Duisterhout JS, Westerhof HP, van der Does E, Cromme WM, Boon WM, et al. The introduction of computer-based patient records in The Netherlands. Ann Int Med 1993;119(10):1036-41.
16. Lamberts H, Wood M, Hofmans-Okkes IM. International primary care classifications: the effect of fifteen years of evolution. Family Prac 1992;9(3):330-9.
17. Anonymous, ATC and DDD values. Geneva: WHO, 1996.
18. Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, van Bemmel JH. Postmarketing surveillance based on electronic patient records: the IPCI project. Method Inform Med 1999;38(4/5):339-44.
19. Logie JW, Clifford GM, Farmer RDT, Meesen BPW. Lower urinary tract symptoms suggestive of benign prostatic obstructionsTriumph: the role of general practice databases. Eur Urol 2001;39(Suppl 3):42-7.